ToxiProofAI is redefining how drug discovery teams predict, monitor, and mitigate safety risks across the drug development lifecycle.
Built specifically for complex biological therapies, the platform integrates multi-omics, real-world toxicology data, and advanced machine learning to deliver early, actionable insight into potential immune-related adverse events (irAEs) and off-target liabilities. By detecting subtle biological patterns that conventional tools often miss, ToxiProofAI helps researchers design safer modalities, prioritize the right candidates, and avoid costly late-stage surprises.
During clinical development, ToxiProofAI supports patient selection, dose optimization, and early detection of toxicity signals, ultimately de-risking trials and accelerating time to meaningful clinical readouts. By transforming safety assessment from a reactive process into a predictive, data-driven capability, ToxiProofAI empowers organizations to advance innovative drugs, such as IO therapies with greater confidence, speed, and precision.
